.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The White Spot Syndrome Virus (WSSV) remains a persistent and significant threat to the global shrimp aquaculture industry. However, its complex pathogenic mechanisms remain only partially understood by the scientific community. Recent research has now identified the envelope structural protein VP53B as a critical determinant of oral infection in species like the whiteleg shrimp and crayfish. Specifically, this study reveals how the virus bypasses host defenses to establish systemic infection.
Researchers investigated the functional role of VP53B using a combination of infection bioassays, protein structure prediction, and protease inhibition assays. Consequently, they discovered that VP53B acts directly as a trypsin inhibitor. Notably, the protein also interacts with host hemocyanin. Because of these interactions, the virus effectively disrupts the host's prophenoloxidase-activating system. This disruption weakens a key innate immune pathway and allows the virus to replicate successfully.
Furthermore, the study highlights that VP53B is essential for the per os (oral) route of infection. In India, where shrimp farming is a cornerstone of the coastal economy, these molecular insights are highly valuable for developing biosecurity strategies. Therefore, targeting the VP53B protein could lead to the development of effective therapeutic interventions. Ultimately, these findings provide a roadmap for future research into neutralizing viral envelope proteins to protect aquatic livestock.
VP53B is an envelope structural protein that acts as a trypsin inhibitor. It interacts with host hemocyanin to disrupt the shrimp\'s innate immune response, specifically the prophenoloxidase-activating system.
No, the virus is not zoonotic. It is not a threat to human health or food safety, as it specifically targets decapod crustaceans like shrimp, crabs, and lobsters.
Since no effective treatments currently exist for WSSV, identifying VP53B as a critical infectivity factor allows scientists to develop targeted therapies and vaccines to prevent massive crop losses.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical or veterinary advice. Refer to the latest local and national guidelines for clinical practice.
References
Xia W et al. White Spot Syndrome Virus Envelope Protein VP53B Functions as a Trypsin Inhibitor and Interacts With Hemocyanin. J Fish Dis. 2026 Apr 12. doi: 10.1111/jfd.70183. PMID: 41966821.
Sanchez-Paz A. White spot syndrome virus: an overview on an emergent concern. Vet Res. 2010;41(6):43. doi: 10.1051/vetres/2010015.
World Organisation for Animal Health (WOAH). Infection with white spot syndrome virus. Aquatic Manual. 2023.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research identifies the WSSV envelope protein VP53B as a trypsin inhibitor that disrupts shrimp immunity, offering a new target for therapeutic interven...
4 months ago
A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
